FindTrial
Sign In

Formulation and standardization of Yazd Meybod ethno-topical preparation made from cotton (Gossypium herbaceum L.) to evaluate the effect on cutaneous Leishmaniasis, a randomized, double blind, placebo controlled trial.

Formulation and standardization of Yazd Meybod ethno-topical preparation made from cotton (Gossypium herbaceum L.) to evaluate the effect on cutaneous Leishmaniasis, a randomized, double blind, placebo controlled trial.

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220131053899N1
Enrollment
70
Registered
2022-05-14
Start date
2022-05-22
Completion date
Unknown
Last updated
2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cutaneous leishmaniasis. Cutaneous leishmaniasis

Interventions

Intervention 1: Each patient receives one milliliter of medication per square centimeter of lesion multiplication on treatment days plus a bandage to cover the lesion and prevent loss of topical medic

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Cannot be using any kind of therapy for leishmaniasis No lesions with a diameter bigger than 3 centimeters Have no kind of immune deficiency diseases No lesions located on the face or joints and have less than 5 lesions Patients with less than 5 ulcers

Exclusion criteria

Exclusion criteria: Any severe side effects or allergies Patients that do not apply the remedy daily or perform the protocol correctly

Design outcomes

Primary

MeasureTime frame
Ulcer diameter. Timepoint: 30 days after starting treatment. Method of measurement: caliper.—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Mohammad Mosadegh

Tehran University of Medical Sciences

ali.moh.mosadegh@gmail.com+98 21 8897 6527

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026